Vanguard Global Advisers
GRDN

Vanguard Global Advisers’s Guardian Pharmacy Services GRDN Stock Holding History

Vanguard Global Advisers’s Portfolio GRDN Stock Details GRDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$587K Buy
14,017
+2,752
+24% +$107K ﹤0.01% 2028
2026
Q1 		$424K Buy
+11,265
New +$368K ﹤0.01% 2113

Other funds holding GRDN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
VCM
Valiant Capital Management San Francisco, California $2.48B AUM 57.08% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

Vanguard Global Advisers's GRDN Position: Q2 2026 in Review

Vanguard Global Advisers increased its Guardian Pharmacy Services (GRDN) stake by 24% in Q2 2026, buying an estimated $107K and bringing the position to 14,017 shares worth $587K. The position accounts for ﹤0.01% of the portfolio, ranked #2028.

Vanguard Global Advisers first reported a position in GRDN in Q1 2026 and has held it in 2 quarters since. 188 funds tracked by Wall St. Rank hold GRDN as of Q2 2026.

  • Vanguard Global Advisers held 14,017 shares of Guardian Pharmacy Services worth $587K as of Q2 2026.
  • Vanguard Global Advisers bought 2,752 Guardian Pharmacy Services shares in Q2 2026, an estimated $107K.
  • Guardian Pharmacy Services made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #2028 holding.
  • Vanguard Global Advisers first reported a position in Guardian Pharmacy Services in Q1 2026 and has held it in 2 quarters since.
  • 188 funds tracked by Wall St. Rank held Guardian Pharmacy Services as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.